Author: James Love
KEI Briefing Note 2024:8. The Basic Proposal for the Design Law Treaty (DLT) and its inappropriate restrictions on transparency
KEI Briefing Note 2024:8, The Basic Proposal for the Design Law Treaty (DLT) and its inappropriate restrictions on transparency
KEI Comments to NIH on Exclusive License to T-Cure Biosciences for Anti-KK-LC-1 T Cell Receptors Patents
KEI-NIH-T-Cure-Biosciences22Oct2024 Knowledge Ecology International (KEI) objects to the “Prospective Grant of an Exclusive Patent License: Anti-KK-LC-1 T Cell Receptors” (89 FR 81089) to T-Cure Biosciences, Inc. (T-Cure). Among other things, KEI said the NIH needs to be more forthcoming in… Continue Reading
KEI asks HHS to stop opposing the publishing of terms regarding equitable access in funding contracts
KEI2HHS19Sep2024 September 19, 2024 Emily Bleimund, JD, MA Director, Office of Trade and Health U.S. Department of Health and Human Services Steven T. Smith National Institute of Allergy and Infectious Diseases (NIAID) Representative, Geneva, Switzerland Dear Emily and Steven, I… Continue Reading
September 16, 2024 version of the negotiating text for a WHO pandemic agreement
KEI comment to USPTO on the need for a statutory experimental use exception for patents
The USPTO has a request for comment on the need for a statutory experimental use exception for patents. (89 FR 53963). The USPTO uploads the comments to Regulations.Gov, docket PTO-C-2024-0023. KEI filed comments on September 10, 2024: KEI-Experimental-use-exception-10Sept2024 September 10,… Continue Reading
KEI letter to the NIH regarding need for better reporting on the utilization of licensed inventions and access in developing countries
The PDF version of the letter has all tables and footnotes: KEI-NIH-28Aug2028 August 28, 2024 Abby Rives, JD Division Director Technology Transfer and Innovation Policy National Institutes for Health Vladimir Knezevic, MD Senior Advisor for Commercial Evaluation Technology Advancement Office… Continue Reading
NIH announces new policy to deal with access to NIH licensed inventions
In a notice to the federal register, the NIH is announcing a new policy to address issues of access and equity in the licensing of NIH patented inventions. (The Federal Register notice is here. Secretary Becerra announcement is here). The… Continue Reading
Letter to Anne Yu, Director for Global Pandemic Preparedness, NSC, on negotiations for WHO pandemic agreement
This was sent via email today. Jamie ————— May 1, 2024 Anne Yu Director for Global Pandemic Preparedness Development, Global Health and Humanitarian Response, National Security Council Staff, Executive Office of the President Dear Anne Yu, I’m guessing you are… Continue Reading